This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, R. E.
Right arrow Articles by Kontoyiannis, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, R. E.
Right arrow Articles by Kontoyiannis, D. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2002, p. 3208-3214, Vol. 46, No. 10
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.10.3208-3214.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Itraconazole Preexposure Attenuates the Efficacy of Subsequent Amphotericin B Therapy in a Murine Model of Acute Invasive Pulmonary Aspergillosis

Russell E. Lewis,1,2 Randall A. Prince,1,2 Jingduan Chi,2 and Dimitrios P. Kontoyiannis1,2*

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M. D. Anderson Cancer Center,1 University of Houston College of Pharmacy, Houston, Texas 770302

Received 12 February 2002/ Returned for modification 12 May 2002/ Accepted 24 June 2002

Antagonism has been described in vitro and in vivo for azole-polyene combinations against Aspergillus species. Using an established murine model of invasive pulmonary aspergillosis, we evaluated the efficacy of several amphotericin B (AMB) dosages given alone or following preexposure to itraconazole (ITC). Mice were immunosuppressed with cortisone acetate and cyclophosphamide. During immunosuppression, animals were administered either ITC solution (50 mg/kg of body weight) or saline by oral gavage twice daily for 3 days prior to infection. Infection was induced by intranasally inoculating mice with a standardized conidial suspension (1 x 108 CFU/ml) of Aspergillus fumigatus strain AF 293. AMB was then administered by daily intraperitoneal injections (0.25, 0.5, 1.0, and 3.0 mg/kg) starting 24 h after inoculation and continuing for a total of 72 h. Drug pharmacokinetics of AMB and ITC in plasma were determined by high-performance liquid chromatography. Four different endpoints were used to examine the efficacy of antifungal therapy: (i) viable counts from harvested lung tissue (in CFU per milliliter), (ii) the whole-lung chitin assay, (iii) mortality at 96 h, and (iv) histopathology of representative lung sections. At AMB doses of >0.5 mg/kg/day, fewer ITC-preexposed mice versus non-ITC-preexposed mice were alive at 96 h (0 to 20 versus 60%, respectively). At all time points, the fungal lung burden was consistently and significantly higher in animals preexposed to ITC, as measured by the CFU counts (P = 0.001) and the chitin assay (P = 0.03). Higher doses of AMB did not overcome this antagonism. ITC preexposure was associated with poorer mycological efficacy and survival in mice treated subsequently with AMB for invasive pulmonary aspergillosis.

* Corresponding author. Mailing address: Department of Infectious Diseases, Box 402, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Phone: (713) 792-6237. Fax: (713) 792-6839. E-mail: dkontoyi{at}mdanderson.org.

Antimicrobial Agents and Chemotherapy, October 2002, p. 3208-3214, Vol. 46, No. 10
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.10.3208-3214.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Quezada, G., Koshkina, N. V., Zweidler-McKay, P., Zhou, Z., Kontoyiannis, D. P., Kleinerman, E. S. (2008). Intranasal Granulocyte-Macrophage Colony-Stimulating Factor Reduces the Aspergillus Burden in an Immunosuppressed Murine Model of Pulmonary Aspergillosis. Antimicrob. Agents Chemother. 52: 716-718 [Abstract] [Full Text]  
  • Lewis, R. E., Liao, G., Hou, J., Chamilos, G., Prince, R. A., Kontoyiannis, D. P. (2007). Comparative Analysis of Amphotericin B Lipid Complex and Liposomal Amphotericin B Kinetics of Lung Accumulation and Fungal Clearance in a Murine Model of Acute Invasive Pulmonary Aspergillosis. Antimicrob. Agents Chemother. 51: 1253-1258 [Abstract] [Full Text]  
  • McLellan, G. J., Aquino, S. M., Mason, D. R., Kinyon, J. M., Myers, R. K. (2006). Use of Posaconazole in the Management of Invasive Orbital Aspergillosis in a Cat. Journal of the American Animal Hospital Association 42: 302-307 [Abstract] [Full Text]  
  • Wiederhold, N. P., Tam, V. H., Chi, J., Prince, R. A., Kontoyiannis, D. P., Lewis, R. E. (2006). Pharmacodynamic Activity of Amphotericin B Deoxycholate Is Associated with Peak Plasma Concentrations in a Neutropenic Murine Model of Invasive Pulmonary Aspergillosis. Antimicrob. Agents Chemother. 50: 469-473 [Abstract] [Full Text]  
  • Lionakis, M. S., Chamilos, G., Lewis, R. E., Wiederhold, N. P., Raad, I. I., Samonis, G., Kontoyiannis, D. P. (2006). Pentamidine Is Active in a Neutropenic Murine Model of Acute Invasive Pulmonary Fusariosis. Antimicrob. Agents Chemother. 50: 294-297 [Abstract] [Full Text]  
  • Olson, J. A., Adler-Moore, J. P., Smith, P. J., Proffitt, R. T. (2005). Treatment of Candida glabrata Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin. Antimicrob. Agents Chemother. 49: 4895-4902 [Abstract] [Full Text]  
  • Lionakis, M. S., Lahdenranta, J., Sun, J., Liu, W., Lewis, R. E., Albert, N. D., Pasqualini, R., Arap, W., Kontoyiannis, D. P. (2005). Development of a Ligand-Directed Approach To Study the Pathogenesis of Invasive Aspergillosis. Infect. Immun. 73: 7747-7758 [Abstract] [Full Text]  
  • Cacciapuoti, A., Gurnani, M., Halpern, J., Norris, C., Patel, R., Loebenberg, D. (2005). Interaction between Posaconazole and Amphotericin B in Concomitant Treatment against Candida albicans In Vivo. Antimicrob. Agents Chemother. 49: 638-642 [Abstract] [Full Text]  
  • Kontoyiannis, D. P., Lewis, R. E., Tattevin, P., Bareau, B., Camus, C., Marty, F. M., Lowry, C. M., Schneemann, M., Imhof, A., Danaher, P. J., Jones, B. L., McLintock, L. A., Walsh, T. J., Donowitz, G. R., dePauw, B. E. (2005). Caspofungin versus liposomal amphotericin B for empirical therapy.. NEJM 352: 410-414 [Full Text]  
  • Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A., Ghannoum, M. A. (2005). Combination Treatment of Invasive Fungal Infections. Clin. Microbiol. Rev. 18: 163-194 [Abstract] [Full Text]  
  • Lewis, R. E., Wiederhold, N. P., Chi, J., Han, X. Y., Komanduri, K. V., Kontoyiannis, D. P., Prince, R. A. (2005). Detection of Gliotoxin in Experimental and Human Aspergillosis. Infect. Immun. 73: 635-637 [Abstract] [Full Text]  
  • Cuenca-Estrella, M. (2004). Combinations of antifungal agents in therapy-what value are they?. J Antimicrob Chemother 54: 854-869 [Abstract] [Full Text]  
  • Lewis, R. E., Kantoyiannis, D. P., Najvar, L. K., Graybill, J. R., Cacciapuoti, A. F. (2004). Challenges in Designing Animal Studies To Detect Antagonism of Polyene Activity. Antimicrob. Agents Chemother. 48: 3211-3212 [Full Text]  
  • Najvar, L. K., Cacciapuoti, A., Hernandez, S., Halpern, J., Bocanegra, R., Gurnani, M., Menzel, F., Loebenberg, D., Graybill, J. R. (2004). Activity of Posaconazole Combined with Amphotericin B against Aspergillus flavus Infection in Mice: Comparative Studies in Two Laboratories. Antimicrob. Agents Chemother. 48: 758-764 [Abstract] [Full Text]  
  • Becker, M. J., de Marie, S., Fens, M. H. A. M., Verbrugh, H. A., Bakker-Woudenberg, I. A. J. M. (2003). Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis. J Antimicrob Chemother 52: 428-434 [Abstract] [Full Text]  
  • Graybill, J. R., Bocanegra, R., Najvar, L. K., Hernandez, S., Larsen, R. A. (2003). Addition of Caspofungin to Fluconazole Does Not Improve Outcome in Murine Candidiasis. Antimicrob. Agents Chemother. 47: 2373-2375 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»